Rx Medicare

APS Healthcare, a leading provider of specialty healthcare solutions, and Thomson Reuters, a global business information company, have been selected by the New York State Department of Health to manage the state’s Medicaid clinical best practice utilization review program. The program examines how Medicaid patients utilize medical services and explores patterns of potentially unnecessary care and opportunities for improving patient safety or quality of care.

Read More…

Related Posts

• Oregon Department Of Human Services Selects APS Healthcare To Manage Expanded Statewide Medicaid Program
• New York Medicaid Program Spends More On Long-Term Care Than Programs In Other Northeastern States, Study Finds
• Missouri Best In Using Federal Aid To Combat Medicaid Fraud, Other States Fight Over Federal Rules
• New York Paid $28M In Medicaid Payments For 20,000 People Receiving Benefits In Other States, Audit Finds
• Jobs Bill Missing Medicaid Money For States, Governors Call For Change
• Walgreens Pharmacies Remain In Washington Medicaid Program; Talks Continue With State Of Washington
• State Round Up: Florida Considers Eliminating Popular Medicaid Plan; State Program For Low-Income Adults Changing In Minn.
• Ohio Changes Medicaid Drug Program, N.C. Weighs Cuts In Medicaid Personal Care Services
• States Struggle With Budget Cuts, Increased Medicaid Pressure
• New York Cuts Drug Reimbursements, States Trim Tobacco Prevention Funding
• A New Era Of Paperless Medicaid Enrollment Is Launched In New York City
• States Experience Medicaid Changes And Offer New Models For Reform
• Medicaid Enrollments Jump But States Are Trying To Cut Costs
• States Worry Over Medicaid Expansion; Montana Expands Kids Coverage
• Governors Question Medicaid Expansion While Some States Do More With CHIP

Tags: best, clinical, easing, healthcare, manage, medicaid, practices, program, reuters, review, states, thomson, york

This entry was posted on Saturday, April 18th, 2009 at 2:04 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.